Effect of gender on reporting of MMR adverse events in Saudi Arabia.
East Mediterr Health J
; 9(1-2): 152-8, 2003.
Article
in En
| MEDLINE
| ID: mdl-15562745
ABSTRACT
We evaluated the safety of a measles-mumps-rubella (MMR) immunization campaign for Saudi children (age range 6-13 years) and gender differences in reporting post-MMR adverse events. After vaccinations were administered, we monitored 160 schools for 14 days and 19 hospitals in the 8 cities under study for 10 weeks. Incidence rates were all MMR adverse events, 26.5/10,000 MMR vaccines (significantly higher in females than males); Urabe strain aseptic meningitis, 1.0/295,000; fever, 40.2/10,000 (females) and 0.9/10,000 (males); and parotitis, 5.4/10,000 (females) and 0.9/10,000 (males). Combined MMR vaccine containing the Urabe mumps strain was safe for children aged 6-13 years. Gender differences regarding reactogenicity were evident and should be considered when designing future studies.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Data Collection
/
Adverse Drug Reaction Reporting Systems
/
Measles-Mumps-Rubella Vaccine
Type of study:
Etiology_studies
/
Evaluation_studies
/
Incidence_studies
/
Prognostic_studies
/
Risk_factors_studies
/
Screening_studies
Aspects:
Determinantes_sociais_saude
Limits:
Adolescent
/
Child
/
Female
/
Humans
/
Male
Country/Region as subject:
Asia
Language:
En
Journal:
East Mediterr Health J
Journal subject:
MEDICINA
Year:
2003
Document type:
Article
Affiliation country:
Saudi Arabia